Table 1 Summary of The Cancer Genome Atlas RNA-seq data sets used in this study.
Cancer type | Number of nontumour samples | Number of tumour samples | Sequencing strategy | Number of mappable reads | Number of detectable pseudogenes |
|---|---|---|---|---|---|
Breast invasive carcinoma | 105 | 837 | Paired-end | 161 M | 747 |
Kidney renal clear cell carcinoma | 67 | 448 | Paired-end | 166 M | 712 |
Lung squamous cell carcinoma | 17 | 220 | Paired-end | 171 M | 813 |
Ovarian serous cystadenocarcinoma | 0 | 412 | Paired-end | 170 M | 670 |
Glioblastoma multiforme | 0 | 154 | Paired-end | 106 M | 875 |
Colorectal carcinoma | 0 | 228 | Single-end | 22 M | 168 |
Uterine corpus endometrioid carcinoma | 4 | 316 | Single-end | 26 M | 181 |
